No need to be sad
21 October 2003

The Dutch conglomerate s profitability is under pressure because of growing generic competition to its main drug. But Pfizer s drugmaking tieup with Akzo, and the company s willingness to dispose of some chemicals assets, mean sunnier days lie ahead.